Eli Lilly (LLY) says Foundayo, the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions, starts at USD 25/month with commercial coverage and USD 149/month with self-pay

Eli Lilly's announcement about Foundayo pricing suggests a strategic move to increase market accessibility for its GLP-1 weight loss treatment.

Newsquawk StaffPublished On the live feed at 9 more headlines followed before this page went public
Newsquawk headlinesUTC

EU Trade Commissioner Sefcovic is to visit the US on April 23rd-24th, Politico reports

The BoE plans to clamp down on a tool that life insurers have used to offload billions of pounds of liabilities, often concerning deals with PE firms, Bloomberg reports, citing sources

Eli Lilly (LLY) says Foundayo, the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions, starts at USD 25/month with commercial coverage and USD 149/month with self-pay

Former NY Fed President Dudley says the Fed should and likely will take no action until the scale, duration and effects of the shock become clearer, despite the fragile ceasefire, according to a Bloomberg opinion piece

EU energy chief Jorgensen says EU plans to ease enforcement of its methane-import rules to avoid jeopardising gas supply, Bloomberg reports

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

With a competitive price point and commercial coverage, this launch may enhance their revenue potential and provide a positive read-through for the pharmaceuticals sector, particularly in the weight loss market.

Related headlines

The whole workspace, free to try.

Try it free